Two Whole-Time Directors resign from Bliss GVS Pharma

Kmp ResignedManagement Changes View source PDF Explain this filing

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.9%Reaction day

₹204.50

prior close

₹208.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.5%+5.4% vs market

Pharmaceuticals peers, median of 159sector-0.0%+4.9% vs sector

On the reaction day the stock moved 5.4 pts more than Nifty Microcap 250 and 4.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.1

10m

-0.7

15m

-0.1

30m

+1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.9-0.5+5.4-0.0+4.9

Next day

+6.6-1.0+7.6-0.2+6.7

+5.6-2.5+8.1-1.9+7.5

+8.1-3.2+11.2-2.4+10.5

+13.1-2.2+15.4-2.2+15.4

+12.4-1.9+14.3-1.9+14.3

+9.3-3.5+12.8-2.9+12.3

15d

+5.8-8.8+14.6-6.7+12.5

+5.8-9.3+15.1-6.7+12.5

+27.6-4.5+32.2-3.7+31.3

+33.5+5.4+28.1+2.9+30.6

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Two Whole-Time Directors of Bliss GVS Pharma, Mrs. Shruti Vishal Rao and Dr. Vibha Gagan Sharma, have resigned with effect from February 10, 2026, citing other professional commitments. Both are daughters of the company's MD and CEO, Mr. Narsimha Shibroor Kamath. They also stepped down from all board committees of the company and its subsidiaries.

Likely market impact

Two promoter-family executive directors exiting could raise governance and continuity concerns; watch for succession updates.